Long-Term Liabilities: The sum of all non-current liabilities.
IGM Biosciences, Inc. (IGMS) had Long-Term Liabilities of $179.90M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$2.68M |
|
$-195.79M |
|
-- |
|
$2.68M |
|
$211.26M |
|
$-208.58M |
|
$12.79M |
|
$-195.79M |
|
$-195.79M |
|
$-195.79M |
|
$-195.79M |
|
$-195.79M |
|
$-195.79M |
|
$-208.58M |
|
$-206.35M |
|
60.52M |
|
60.52M |
|
$-3.24 |
|
$-3.24 |
|
| Balance Sheet Financials | |
$193.62M |
|
$32.51M |
|
$72.09M |
|
$265.71M |
|
$37.64M |
|
-- |
|
|
Long-Term Liabilities |
$179.90M |
$217.54M |
|
$48.17M |
|
$48.17M |
|
$48.17M |
|
59.65M |
|
| Cash Flow Statement Financials | |
$-153.00M |
|
$64.16M |
|
$2.39M |
|
$113.11M |
|
$26.66M |
|
$-86.45M |
|
$38.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-7785.74% |
|
-7785.74% |
|
-7702.54% |
|
-7308.51% |
|
-7308.51% |
|
$-158.81M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-406.45% |
|
-406.45% |
|
-73.69% |
|
-406.45% |
|
$0.81 |
|
$-2.62 |
|
$-2.53 |
|